 |
| On the morning of the morning of the 20th, when the second dose of Pfizer’s vaccine was carried out, subjects are being vaccinated at the Central Vaccination Center at the National Medical Center in Jung-gu, Seoul. 2021.3.20/News1 © News1 Reporter Park Ji-hye |
The number of newly vaccinated vaccines for the novel coronavirus infection (Corona 19) was counted as 939 at 0 o’clock on the 21st. The number of daily vaccinations decreased significantly due to the weekend effect. Up to this day, the cumulative primary vaccination was 67,6587 people, and the national standard vaccination rate was 1.3%.
Compared to 0:00 the previous day, the number of reported adverse reactions increased by 25. All were common cases after vaccination, such as muscle pain, headache, fever, chills, and nausea. There were no newly added cases of anaphylaxis, serious suspicions such as convulsions, or death reports.
According to the Corona 19 Vaccination Response Promotion Team on the 21st, the number of corona 19 primary vaccinations as of 0 o’clock on the day increased by 939 to 67,6587 people. Among them, 611,100 people were vaccinated against AstraZeneca (AZ) and 5,7487 people were vaccinated against Pfizer.
The first vaccination rate was 1.3% based on 58,82,5932 people nationwide (Statistics Office at the end of January 2021). Except for the Janssen vaccine, which will be introduced in the future, the remaining vaccines need to be vaccinated twice to form immunity.
The areas of 939 new primary inoculations are 13 in Seoul, 46 in Busan, 223 in Daegu, 382 in Incheon, 194 in Daejeon, 59 in Gyeonggi, 12 in Chungnam, and 10 in Jeonbuk. There were no additional vaccinations in Gwangju, Ulsan, Sejong, Gangwon, Chungbuk, Jeonnam, Gyeongbuk, Gyeongnam, and Jeju the day before.
The number of cases reported as adverse reactions after the COVID-19 vaccination was 9782, an increase of 25 as of 0 o’clock on the day. All 25 newly reported cases were common cases such as headache, fever, nausea, and vomiting, which can be common after vaccination. The cumulative number of these reported cases recorded 9666.
There were 11 cases of serious suspicion such as convulsions, the same as the previous day. There were 4 nervous system reactions such as convulsions and 7 hospitalized in the intensive care unit. The number of suspected cases of anaphylaxis remained the same as the previous day in 89 cases. By category, there were 84 anaphylactic reactions and 5 suspected anaphylactic shock cases.
The suspected cases of anaphylaxis are classified into three categories: △ suspected anaphylaxis shock, △ suspected anaphylaxis, and △ suspected anaphylaxis. Severe adverse reactions with a risk of death are classified as anaphylaxis shock and refer to cases in which an acute allergic reaction occurs within 30 minutes after vaccination.
As there were no additional reports of deaths, 16 people were maintained as the same number as the previous day, respectively. Of these, 14 had a preliminary conclusion that there was no causality between death and vaccination, and two are under investigation.
Meanwhile, the currently received reports of adverse reactions were reported because they were suspected of adverse reactions after vaccination, and the causality was not confirmed. Epidemiological investigations are conducted for serious cases such as death or anaphylaxis to evaluate causality.
 |
| © News1 Designer Lee Ji-won |